FindTrial
Sign In

Evaluation of Homeopathic Medicine Histaminum Hydrochloricum 3X in Managing Allergic Conditions of the Upper Respiratory Tract with High Eosinophil Count in Patients Aged 10 50 Years.

Exploring action of sarcode Histaminum Hydrochloricum 3x in reducing eosinophilia in case of Allergic diseases in upper respiratory tract in age group of 10 years to 50 years. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105897
Enrollment
50
Registered
2026-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J393- Upper respiratory tract hypersensitivity reaction, site unspecified

Interventions

Intervention1: HISTAMINUM HYDROCHLORICUM 3x (Homeopathic Preparation): The homeopathic sarcode Histaminum Hydrochloricum 3X will be administered to patients aged 10 50 years suffering from allergic di

Sponsors

C D Pachchigar College Of Homoeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants eligible for this study will include individuals aged 10 50 years who are clinically diagnosed with allergic diseases of the upper respiratory tract and have an Absolute Eosinophil Count (AEC) greater than 500 cells/ L. Only patients meeting these criteria will be included for treatment with Histaminum Hydrochloricum 3X.

Exclusion criteria

Exclusion criteria: Patients will be excluded from the study if they are taking corticosteroids, antihistamines, or immunosuppressive drugs, have parasitic or autoimmune diseases, are pregnant or lactating women, or suffer from chronic systemic illnesses such as tuberculosis or malignancy.

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of Histaminum Hydrochloricum 3x in reducing absolute eosinophil count in patients aged 10 years to 50 years diagnosed with allergic upper respiratory tract diseases over a period of 6 weeks.Timepoint: 9 months—

Secondary

MeasureTime frame
To assess the improvement in clinical symptoms (e.g., sneezing, nasal congestion, itching, cough) in the same patient group after administration of Histaminum Hydrochloricum 3x for 6 weeks.Timepoint: 9 months—

Countries

India

Contacts

Public ContactDr Naitik Mehta

C D Pachchigar College Of Homoeopathic Medicine And hospital

naitik4ever44@gmail.com8460807754

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026